June 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 135.25 billion in 2025 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
June 2026
The U.S. over the counter (OTC) drugs market size is expected to increase from USD 24.81 billion in 2025 and is predicted to hit USD 46.67 billion by 2035, with a CAGR of 6.52%.
March 2026
The global over the counter (OTC) test market size is estimated to hit around USD 69.23 billion by 2035 increasing from USD 24.69 billion in 2025, with a CAGR of 10.86%.
January 2026
The global over-the-counter (OTC) analgesics market size was valued USD 31.89 billion in 2025 and is estimated to hit around USD 45.77 billion by 2035 with a CAGR of 3.68%.
June 2026
The global atherosclerosis drugs market size is projected to hit around USD 25.07 billion by 2035, increasing from USD 17.60 billion in 2025, with a CAGR of 3.60%.
June 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
May 2026
The global power over Ethernet market size is expected to increase from USD 1.64 billion in 2025 to hit around USD 4.87 billion by 2035, growing at a CAGR of 11.50%.
May 2026
The global synthetic lethality-based drugs and targets market size was evaluated at USD 1.86 billion in 2025 and is predicted to hit around USD 9.37 billion by 2035, growing at a CAGR of 17.52%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
March 2026
The global power over ethernet chipsets market size was evaluated at USD 0.99 billion in 2025 and is predicted to hit around USD 3.14 billion by 2035, growing at a CAGR of 12.24%.
February 2026
The global automotive OTA (over-the-air) enablement component market size is estimated to hit around USD 15.94 billion by 2035 increasing from USD 4.80 billion in 2025, with a CAGR of 12.75%.
February 2026
The global anthelmintic drugs market size was evaluated at USD 4.06 billion in 2025 and is predicted to hit around USD 9.01 billion by 2035, growing at a CAGR of 8.30%.
December 2025
The over the top (OTT) market size is accounted at USD 399.12 billion in 2025 and is projected to surpass around USD 2816.85 billion by 2034 with a CAGR of 24.42%.
August 2025
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
August 2025
The global general anesthesia drugs market size was calculated at USD 5.40 billion in 2024 and is projected to surpass around USD 7.79 billion by 2034, with a CAGR of 3.73%.
July 2025
The global anesthesia drugs market size reached USD 7.53 billion in 2025 and is expected to attain around USD 12.25 billion by 2035 with a CAGR of 4.99%.
July 2025
The global lipase inhibitors obesity drugs market size was estimated at USD 1.25 billion in 2024 and is expected to hit around USD 4.94 billion by 2034, growing at a CAGR of 14.72%.
July 2025
The global tumor necrosis factor inhibitor drugs market size is projected to hit around USD 51.55 billion by 2034 from USD 42.86 billion in 2024 with a CAGR of 1.86%.
June 2025
The global topical drugs CDMO market size was exhibited at USD 46.62 billion in 2024 and is predicted to surpass around USD 136.39 billion by 2034, with a CAGR of 11.33%.
June 2025
The global inhalable drugs market size was valued at USD 35.44 billion in 2024 and is projected to cross around USD 65.51 billion by 2034 with a CAGR of 5.57%.
July 2025
The global self-monitoring blood glucose devices market size is expected to hit around USD 33.30 billion by 2034 from USD 11.27 billion in 2024, with a CAGR of 11.44%.
July 2025
The global acute migraine treatment market size was valued at USD 3.46 billion in 2024 and is expected to surge around USD 10.08 billion by 2034 with a CAGR of 11.30%.
June 2026
The global gene therapy market size was exhibited at USD 11.07 billion in 2025 and is predicted to hit around USD 63.52 billion by 2035 with a solid CAGR of 19.09%.
June 2026
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 18.43 billion by 2035 increasing from USD 8.44 billion in 2025, with a CAGR of 8.12%.
June 2026
The global plasma therapeutics market size is estimated to hit around USD 52.26 billion by 2035 increasing from USD 28.35 billion in 2025, with a CAGR of 6.31%.
June 2026
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
The global cancer therapeutics and biotherapeutics market size was valued at USD 210.73 billion in 2025 and is expected to hit around USD 475.26 billion by 2035, growing at a CAGR of 8.47%.
June 2026
The global rheumatoid arthritis drugs market size was valued at USD 64.35 billion in 2025 and is expected to hit around USD 76.83 billion by 2035, growing at a CAGR of 1.79% from 2026 to 2035.
June 2026
The US cell and gene therapy market size was evaluated at USD 4.09 billion in 2025 and is predicted to hit around USD 20.00 billion by 2035, growing at a CAGR of 17.21%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com